Calendar Enliven Therapeutics, Inc.

Equities

ELVN

US29337E1029

Market Closed - Nasdaq 21:00:00 17/06/2024 BST 5-day change 1st Jan Change
21.56 USD -0.65% Intraday chart for Enliven Therapeutics, Inc. -4.52% +55.78%

Chart calendar Enliven Therapeutics, Inc.

8af45c7d550fe9081391a9ea.F6mr4kVhC8mZgsDkZs71ZE1L21reQksf1YYKEaCCoR0.b_7tsSATaPHY55OcHJnGEnk_nx-5MDx-uvNGUsbykXlb8dKqAiY8pPP6gQ~b06e99ee2bc865b2bf2b7f58cf37acd4

Upcoming events on Enliven Therapeutics, Inc.

Today 17:00 Annual General Meeting
07/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
12/03/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Enliven Therapeutics, Inc.

10/06/2024 20:20 Goldman Sachs Global Healthcare Conference - Fireside Chat
05/06/2024 13:30 Jefferies Global Healthcare Conference - Fireside Chat
14/05/2024 21:05 Q1 2024 Earnings Release
11/04/2024 13:00 Business Update Call
14/03/2024 20:05 Q4 2023 Earnings Release
05/03/2024 17:50 TD Cowen Health Care Conference
09/11/2023 21:05 Q3 2023 Earnings Release
10/08/2023 21:05 Q2 2023 Earnings Release
23/06/2023 16:30 Annual General Meeting
14/06/2023 16:00 Goldman Sachs Global Healthcare Conference
08/06/2023 16:00 Jefferies Global Healthcare Conference
12/05/2023 01:05 Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
-83,5
-85,3
2.08%

-120

EBIT
Million USD
Released
Forecast
Spread
0,00


-38,8
-40,0
3.02%
-83,5
-85,9
2.73%

-116

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-37,7
-39,9
5.61%
-71,6
-74,2
3.53%

-103

Net income
Million USD
Released
Forecast
Spread
-24,7


-37,7
-39,9
5.61%
-71,6
-74,2
3.53%

-103

EPS
USD
Released
Forecast
Spread
-3,17


-3,56
-3,80
6.32%
-2,01
-2,16
7.05%

-2,31

Announcement Date10/11/2221/03/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-16,4
-12,1
-35.69%
-20,1
-16,4
-23.14%
-24,2
-21,7
-11.57%
-22,7
-25,1
9.34%
-26,0
-25,5
-1.82%

-28,3


-30,5


-31,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-14,7
-12,0
-23.21%
-16,7
-14,9
-12.6%
-20,8
-18,5
-12.25%
-19,4
-22,4
13.52%
-22,7
-23,9
4.9%

-26,1


-27,8


-29,1

Net income
Million USD
Released
Forecast
Spread
-14,7
-12,0
-23.21%
-16,7
-14,9
-12.6%
-20,8
-18,5
-12.25%
-19,4
-22,4
13.52%
-22,7
-23,9
4.9%

-26,1


-27,8


-29,1

EPS
USD
Released
Forecast
Spread
-0,80
-0,52
-53.85%
-0,41
-0,40
-3.36%
-0,51
-0,47
-7.94%
-0,47
-0,54
12.96%
-0,54
-0,57
4.71%

-0,56


-0,62


-0,64

Announcement Date11/05/2310/08/2309/11/2314/03/2414/05/24---

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ELVN Stock
  4. Calendar Enliven Therapeutics, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW